Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
6.34
+0.13 (2.09%)
At close: Jun 26, 2026, 4:00 PM EDT
6.26
-0.08 (-1.22%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Taysha Gene Therapies Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Taysha Gene Therapies stock has a consensus rating of "Strong Buy" and an average price target of $12.85. The average 1-year stock price forecast is 102.68% higher than the current stock price, while the lowest is $10 (+57.73%) and the highest is $19 (+199.68%).
Price Target: $12.85 (+102.68%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Taysha Gene Therapies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 10 | 10 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Keith Tapper CFA BMO Capital | BMO Capital | Buy Maintains $10 → $14 | Buy | Maintains | $10 → $14 | +120.82% | Jun 23, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $8 → $11 | Buy | Maintains | $8 → $11 | +73.50% | Jun 23, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $10 | Buy | Reiterates | $10 | +57.73% | Jun 23, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $13 | Buy | Maintains | $13 | +105.05% | Jun 23, 2026 |
| Needham | Needham | Buy Reiterates $12 | Buy | Reiterates | $12 | +89.27% | Jun 22, 2026 |
Financial Forecast
Revenue This Year
1.85M
from 9.77M
Decreased by -81.11%
Revenue Next Year
29.70M
from 1.85M
Increased by 1,508.77%
EPS This Year
-0.44
from -0.32
EPS Next Year
-0.44
from -0.44
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.0M | ||
| Avg | 1.8M | ||
| Low | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 53.5% | ||
| Avg | -81.1% | ||
| Low | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.36 | ||
| Avg | -0.44 | ||
| Low | -0.54 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |